Kezar Life Sciences reports preliminary cash of $276.6M and 68.5M shares outstanding as of Dec 31, 2022

Kezar Life Sciences, Inc.

Preliminary cash, cash equivalents and marketable securities of ~$276.6M as of Dec 31, 2022.
Approximately 68.5 million shares of common stock outstanding as of year-end 2022.
Estimates are unaudited and subject to change upon completion of year-end closing procedures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.